2nd International Symposium on Childhood, Adolescent and Young Adult Hodgkin Lymphoma

Abbas, N

Refractory or Relapsed Hodgkin's Lymphoma Treated with High Dose Chemotherapy Followed by Autologous Stem Cell Transplantation: Experience at SKMCH Lahore

Abel, L

Combined Linkage and Association Studies of Antibodies against EBV Antigens Confirm the Role of HLA Class II Variants in the Control of Anti-EBNA1 IgG Levels and in the Risk of Hodgkin's Lymphoma

Abugova, Y

Treatment of Children and Adolescents with Hodgkin's Lymphoma According to Recommendations of DAL/GPOH-HD Group (Preliminary Results)

Adamkiewicz-Drozynska, E

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Afanasyev, B

Brentuximab Vedotin in Heavily Pretreated Patients with Refractory Hodgkin's Lymphoma

Ahmad, A

Challenges in Treating Hodgkin Lymphoma in a Developing Country: Children Hospital Lahore Experience

Ahmed, M

Refractory or Relapsed Hodgkin's Lymphoma Treated with High Dose Chemotherapy Followed by Autologous Stem Cell Transplantation: Experience at SKMCH Lahore

Akdemir, OU

Evaluation of FDG-PET/CT and Conventional Imaging Techniques in Pediatric Hodgkin Lymphoma Patients in a Single Center

Akyürek, N

Clinical Characteristics and Outcome of Pediatric Patients with Relapsed or Refractory Hodgkin Lymphoma: Gazi University Pediatric Oncology Experience

Akyuz, C

Treatment Results of 102 Patients with Hodgkin Lymphoma under 5 Years of Age

Alabi, S

A Risk Adapted, Response- Based Therapeutic Regimen Using OEPA/COPDAC for the Treatment of Children with High Risk Hodgkin Lymphoma; from the Central American y Dominican Republic Group

Aladjidi, N

Phase 1/2 Study of Brentuximab Vedotin in Pediatric Pts with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 HL Data

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

Ali, AS

Challenges in Treating Hodgkin Lymphoma in a Developing Country: Children Hospital Lahore Experience

Almeida, S

Second Neoplasms in Adolescents and Young Adults with Hodgkin Lymphoma

Hodgkin Lymphoma in Adolescents and Young Adults: Comparing Outcomes

Alsada, Z

Comparison of Serial Plasma Galectin-1, sCD163 and sCD30 with Plasma TARC Levels as Circulating Biomarkers for Response Evaluation in Classical Hodgkin Lymphoma

Alyansky, A

Brentuximab Vedotin in Heavily Pretreated Patients with Refractory Hodgkin's Lymphoma

Amiel, C

Combined Linkage and Association Studies of Antibodies against EBV Antigens Confirm the Role of HLA Class II Variants in the Control of Anti-EBNA1 IgG Levels and in the Risk of Hodgkin's Lymphoma

Appel, B

Treatment of Pediatric Lymphocyte Predominant Hodgkin Lymphoma (LPHL): A Report from the Children's Oncology Group

Arancibia, A

Clinical and Treatment Results of a Group of Children Diagnosed with Hodgkin Lymphoma in a Single Brazilian Institution

Is it Possible to Work together in Latin America? Creation of a Latin American Consortium (CLEHOP)

Armstrong, G

Longitudinal Evaluation of Health Status in Aging Pediatric Hodgkin Lymphoma Survivors: Report from the Childhood Cancer Survivor Study

Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography (CCTA) in Adult Survivors of Childhood Hodgkin Lymphoma

The Evolution of Pediatric Hodgkin Lymphoma Therapy: Contemporary Protocols Significantly Reduce Radiation Exposure of Normal Tissues

Asghar, N

Challenges in Treating Hodgkin Lymphoma in a Developing Country: Children Hospital Lahore Experience

Attarbaschi, A

Fertility Testing in Young Men After Successful Treatment of Hodgkin's Lymphoma with Procarbazine-Free Combination Regimen within the GPOH-HD 2002 Trial

Aydin, B

Treatment Results of 102 Patients with Hodgkin Lymphoma under 5 Years of Age

Badar, F

Refractory or Relapsed Hodgkin's Lymphoma Treated with High Dose Chemotherapy Followed by Autologous Stem Cell Transplantation: Experience at SKMCH Lahore

Baez, F

A Risk Adapted, Response- Based Therapeutic Regimen Using OEPA/COPDAC for the Treatment of Children with High Risk Hodgkin Lymphoma; from the Central American y Dominican Republic Group

Balwierz, W

Results of Thyroid Function Assessment in Children and Adolescents with Hodgkin's Lymphoma Treated According to HD-97 Protocol

Assessment of Gonadal Function in Young Men Treated for Hodgkin's Lymphoma during Childhood and Adolescence

Immunological Status of the Host in Aspect of Epstein-Barr Virus Latency in Pediatric Hodgkin Lymphoma

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Barrios, N

BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela

Barros, M

M2 Macrophages but not M1 Macrophages Are Associated with Worst Outcome in Classical Hodgkin Lymphoma

Genetic Variants of Interleukin 10 (IL10) are Associated with Clinical Outcome and Tumor Microenvironment Composition of Classical Hodgkin Lymphoma (cHL)

PD1+ Cells in Pediatric Classical Hodgkin Lymphoma is Associated with Better Outcome

Bedir, R

PET Based Response Adapted Treatment in Pediatric HD Can Significantly Reduce Use of Radiation Therapy: A Study from Kuwait Cancer Control Centre, Kuwait

Behre, H

Fertility Testing in Young Men After Successful Treatment of Hodgkin's Lymphoma with Procarbazine-Free Combination Regimen within the GPOH-HD 2002 Trial

Beishuizen, A

Phase 1/2 Study of Brentuximab Vedotin in Pediatric Pts with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 HL Data

Belogurova, M

Treatment of Children and Adolescents with Hodgkin's Lymphoma According to Recommendations of DAL/GPOH-HD Group (Preliminary Results)

Bergstraesser, E

Fertility Testing in Young Men After Successful Treatment of Hodgkin's Lymphoma with Procarbazine-Free Combination Regimen within the GPOH-HD 2002 Trial

Bernd, HW

Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD

Berthold, F

Feasibility of VECOPA a Dose-Intensive Regimen for Pediatric Intermediate and Advanced Stage Hodgkin's Lymphoma: Results of the GPOH-HD-2002/VECOPA-Pilot Study

Bertolini, P

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Besson, C

Hodgkin Lymphoma Subtypes and Peripheral B-cell Lymphopenia are Associated with EBV Status in Children and Adolescents in France: A Preliminary Report of the EuroNet LH EPI Project

Combined Linkage and Association Studies of Antibodies against EBV Antigens Confirm the Role of HLA Class II Variants in the Control of Anti-EBNA1 IgG Levels and in the Risk of Hodgkin's Lymphoma

Bhargavi, D

Hodgkin's Lymphoma-Eight Year Experience of a Tertiary Care Center in South India

Bianchi, M

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Blochberger, I

MLL5 as Disease Contributing Gene in Classical Pediatric and Adult Hodgkin Lymphoma

Bob, R

Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD

Bora, H

Clinical Characteristics and Outcome of Pediatric Patients with Relapsed or Refractory Hodgkin Lymphoma: Gazi University Pediatric Oncology Experience

Borzenkova, E

Brentuximab Vedotin in Heavily Pretreated Patients with Refractory Hodgkin's Lymphoma

Boudjemaa, S

Hodgkin Lymphoma Subtypes and Peripheral B-cell Lymphopenia are Associated with EBV Status in Children and Adolescents in France: A Preliminary Report of the EuroNet LH EPI Project

Boudjemaah, S

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

Bouwman, I

HLA Associations in EBV Status Defined Subgroups of Classical Hodgkin Lymphoma

Brämswig, J

Subsequent Malignant Neoplasms in Survivors of Pediatric DAL/GPOH-Hodgkin-Lymphoma Trials

Brice, P

Combined Linkage and Association Studies of Antibodies against EBV Antigens Confirm the Role of HLA Class II Variants in the Control of Anti-EBNA1 IgG Levels and in the Risk of Hodgkin's Lymphoma

Brown, N

Glycoproteomic Profiling of Hodgkin Lymphoma Reveals Novel Proteins that Contribute to the Microenvironment and Have Diagnostic Utility

Brunelli, R

Risk assessment of Solid Secondary Malignancies (SMN) in Childhood and Adolescent Hodgkin Lymphoma (HL) Treated with Radiotherapy (RT): Conventional RT vs. Helical Tomotherapy

Buffardi, S

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Role of Interim FDG-PET for Mediastinal Response Assessment in Pediatric Hodgkin's Lymphoma (HL):Preliminary Results from the Italian AIEOP-LH2004 Protocol

Burdach, S

Feasibility of VECOPA a Dose-Intensive Regimen for Pediatric Intermediate and Advanced Stage Hodgkin's Lymphoma: Results of the GPOH-HD-2002/VECOPA-Pilot Study

MLL5 as Disease Contributing Gene in Classical Pediatric and Adult Hodgkin Lymphoma

Burkhardt, B

Grey Zone Lymphoma in Children and Adolescents: Experience of Pediatric Hodgkin and Non-Hodgkin Study Groups

Burnelli, R

Hodgkin Lymphoma: 30-Year Experience. What is Changed?

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Role of Interim FDG-PET for Mediastinal Response Assessment in Pediatric Hodgkin's Lymphoma (HL):Preliminary Results from the Italian AIEOP-LH2004 Protocol

Buyukpamukcu, M

Treatment Results of 102 Patients with Hodgkin Lymphoma under 5 Years of Age

Caniglia, M

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Carboné, A

Outcome of Spanish Patients outside Euronet-PHL-C1

Carda, J

Second Neoplasms in Adolescents and Young Adults with Hodgkin Lymphoma

Hodgkin Lymphoma in Adolescents and Young Adults: Comparing Outcomes

Carde, P

Combined Linkage and Association Studies of Antibodies against EBV Antigens Confirm the Role of HLA Class II Variants in the Control of Anti-EBNA1 IgG Levels and in the Risk of Hodgkin's Lymphoma

Cardenas, L

BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela

Carrasquel, O

BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela

Caruso, R

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Casanova Fuga, E

Risk assessment of Solid Secondary Malignancies (SMN) in Childhood and Adolescent Hodgkin Lymphoma (HL) Treated with Radiotherapy (RT): Conventional RT vs. Helical Tomotherapy

Cassuto, O

A Dedicated Program for Young Adults who Suffer from Cancer: Experience of the Centre Henri Becquerel, Rouen, France

Castellanos, E

A Risk Adapted, Response- Based Therapeutic Regimen Using OEPA/COPDAC for the Treatment of Children with High Risk Hodgkin Lymphoma; from the Central American y Dominican Republic Group

Castellanos, M

Classical Hodgkin Lymphoma in Guatemalan Children of Age Less than Six Show High pPrevalence of EBV, HGAL and CD137: Prognostic and Therapeutic Implications

Is it Possible to Work together in Latin America? Creation of a Latin American Consortium (CLEHOP)

Castellino, S

Longitudinal Evaluation of Health Status in Aging Pediatric Hodgkin Lymphoma Survivors: Report from the Childhood Cancer Survivor Study

Outcomes and Patterns of Failure in Children/Adolescents with Low Risk Hodgkin Lymphoma (HL) who Are FDG-PET (PET3) Positive after AVPC Therapy

Intensive Therapy Free Survival (ITFS) for Early-Stage Hodgkin Lymphoma (cHL) Including Chemotherapy and Radiation Therapy (IFRT) for Recurrence after Chemotherapy alone

Cecinati, V

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Cellini, M

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Cepelova, M

Cardiovascular Sequelae in Young Adult Survivors of Childhood Hodgkin Lymphoma

Cesarman, E

Beta-2 Microglobulin (B2 M) Genomic Alterations and Absent Protein Expression in Pediatric and Adolescent Classical Hodgkin Lymphoma

Cesaro, S

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Chaber, R

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Chen, L

Treatment of Pediatric Lymphocyte Predominant Hodgkin Lymphoma (LPHL): A Report from the Children's Oncology Group

Outcomes and Patterns of Failure in Children/Adolescents with Low Risk Hodgkin Lymphoma (HL) who Are FDG-PET (PET3) Positive after AVPC Therapy

Intensive Therapy Free Survival (ITFS) for Early-Stage Hodgkin Lymphoma (cHL) Including Chemotherapy and Radiation Therapy (IFRT) for Recurrence after Chemotherapy alone

Chiang, AK

Treatment Outcome of a Multi-Centre Clinical Study of Hodgkin Lymphoma: A Report by Hong Kong Paediatric Haematology and Oncology Study Group

Chiti, A

Role of Interim FDG-PET for Mediastinal Response Assessment in Pediatric Hodgkin's Lymphoma (HL):Preliminary Results from the Italian AIEOP-LH2004 Protocol

Cho, S

Pleural Effusion in Intermediate Hodgkin Lymphoma COG Protocol AHOD0031-Evolution with Therapy and Association with Bulk Mediastinal Disease or Bone, Lung or Pleural Nodular Disease

Retrospective Review of Bone Changes in Hodgkin Lymphoma utilizing CT, 18F FDG-PET, 99mTc-MDPbone Scan and MRI from Children's Oncology Group Intermediate Stage Protocol AHOD0031

Outcomes and Patterns of Failure in Children/Adolescents with Low Risk Hodgkin Lymphoma (HL) who Are FDG-PET (PET3) Positive after AVPC Therapy

Chybicka, A

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Cistaro, A

Role of Interim FDG-PET for Mediastinal Response Assessment in Pediatric Hodgkin's Lymphoma (HL):Preliminary Results from the Italian AIEOP-LH2004 Protocol

Claude, L

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

Cobat, A

Combined Linkage and Association Studies of Antibodies against EBV Antigens Confirm the Role of HLA Class II Variants in the Control of Anti-EBNA1 IgG Levels and in the Risk of Hodgkin's Lymphoma

Cogliatti, S

Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD

Conrad, J

Fertility Testing in Young Men After Successful Treatment of Hodgkin's Lymphoma with Procarbazine-Free Combination Regimen within the GPOH-HD 2002 Trial

Consarino, C

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Constine, L

Treatment of Pediatric Lymphocyte Predominant Hodgkin Lymphoma (LPHL): A Report from the Children's Oncology Group

Outcomes and Patterns of Failure in Children/Adolescents with Low Risk Hodgkin Lymphoma (HL) who Are FDG-PET (PET3) Positive after AVPC Therapy

Intensive Therapy Free Survival (ITFS) for Early-Stage Hodgkin Lymphoma (cHL) Including Chemotherapy and Radiation Therapy (IFRT) for Recurrence after Chemotherapy alone

Contreras, A

Is it Possible to Work together in Latin America? Creation of a Latin American Consortium (CLEHOP)

Coronado, M

Outcome of Spanish Patients outside Euronet-PHL-C1

Correles de Acquatella, G

BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela

Cortesão, E

Second Neoplasms in Adolescents and Young Adults with Hodgkin Lymphoma

Hodgkin Lymphoma in Adolescents and Young Adults: Comparing Outcomes

Coulomb, A

Hodgkin Lymphoma Subtypes and Peripheral B-cell Lymphopenia are Associated with EBV Status in Children and Adolescents in France: A Preliminary Report of the EuroNet LH EPI Project

Cowan, R

The Breast Screening after Radiotherapy Dataset (BARD): a National Initiative to Optimise Screening for Breast cancer in Female Hodgkin Lymphoma Survivors in England

Creidy, R

Hodgkin Lymphoma Subtypes and Peripheral B-cell Lymphopenia are Associated with EBV Status in Children and Adolescents in France: A Preliminary Report of the EuroNet LH EPI Project

Cristofano, C

The Use of DWI WB-MRI in Pediatric Oncology, a Single Institution Experience and Pictorial Essay

Curtillet, C

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

D'Amico, S

Immune Thrombocytopenia at Diagnosis of Hodgkin Lymphoma

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Dadela-Urbanek, A

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Dainese, L

Hodgkin Lymphoma Subtypes and Peripheral B-cell Lymphopenia are Associated with EBV Status in Children and Adolescents in France: A Preliminary Report of the EuroNet LH EPI Project

Davies, S

The Breast Screening after Radiotherapy Dataset (BARD): a National Initiative to Optimise Screening for Breast cancer in Female Hodgkin Lymphoma Survivors in England

Daw, S

Does Pathological Variability in Paediatric Nodular Lymphocyte Predominant Hodgkin Lymphoma Have Clinical Prognostic Significance?

Phase 1/2 Study of Brentuximab Vedotin in Pediatric Pts with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 HL Data

De Alarcon, P

A Risk Adapted, Response- Based Therapeutic Regimen Using OEPA/COPDAC for the Treatment of Children with High Risk Hodgkin Lymphoma; from the Central American y Dominican Republic Group

de Jong, D

Long Non-Coding RNAs Are Commonly Deregulated in Hodgkin Lymphoma

Denisov, N

Treatment of Children and Adolescents with Hodgkin's Lymphoma According to Recommendations of DAL/GPOH-HD Group (Preliminary Results)

De Santis, R

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

de Wolf-Peeters, C

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T cell/Histiocyte Rich Large B Cell Lymphoma Endpoints of a Spectrum of one Disease?

Diakonova, Y

Treatment of Children and Adolescents with Hodgkin's Lymphoma According to Recommendations of DAL/GPOH-HD Group (Preliminary Results)

Dibar, E

Is it Possible to Work together in Latin America? Creation of a Latin American Consortium (CLEHOP)

Pediatric Hodgkin Lymphoma through Clinical Trials in Argentina in the Past 46 Years: The GATLA Experience

Di Benedetto, V

Immune Thrombocytopenia at Diagnosis of Hodgkin Lymphoma

Di Cataldo, A

Immune Thrombocytopenia at Diagnosis of Hodgkin Lymphoma

Diepstra, A

HLA Associations in EBV Status Defined Subgroups of Classical Hodgkin Lymphoma

Long Non-Coding RNAs Are Commonly Deregulated in Hodgkin Lymphoma

Comparison of Serial Plasma Galectin-1, sCD163 and sCD30 with Plasma TARC Levels as Circulating Biomarkers for Response Evaluation in Classical Hodgkin Lymphoma

Donadieu, J

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

Donovan, D

Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography (CCTA) in Adult Survivors of Childhood Hodgkin Lymphoma

Dörffel, W

Subsequent Malignant Neoplasms in Survivors of Pediatric DAL/GPOH-Hodgkin-Lymphoma Trials

Döring, C

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T cell/Histiocyte Rich Large B Cell Lymphoma Endpoints of a Spectrum of one Disease?

Doukoure, B

Hodgkin Lymphoma Subtypes and Peripheral B-cell Lymphopenia are Associated with EBV Status in Children and Adolescents in France: A Preliminary Report of the EuroNet LH EPI Project

Drachtman, R

Definition and Significance of Osseous Involvement in Newly Diagnosed Pediatric Hodgkin Lymphoma

Pleural Effusion in Intermediate Hodgkin Lymphoma COG Protocol AHOD0031-Evolution with Therapy and Association with Bulk Mediastinal Disease or Bone, Lung or Pleural Nodular Disease

Drigo, A

Risk assessment of Solid Secondary Malignancies (SMN) in Childhood and Adolescent Hodgkin Lymphoma (HL) Treated with Radiotherapy (RT): Conventional RT vs. Helical Tomotherapy

Dunphy, C

Outcomes and Patterns of Failure in Children/Adolescents with Low Risk Hodgkin Lymphoma (HL) who Are FDG-PET (PET3) Positive after AVPC Therapy

Intensive Therapy Free Survival (ITFS) for Early-Stage Hodgkin Lymphoma (cHL) Including Chemotherapy and Radiation Therapy (IFRT) for Recurrence after Chemotherapy alone

Durand, JB

Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography (CCTA) in Adult Survivors of Childhood Hodgkin Lymphoma

Dzikowska, K

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Ebetsberger-Dachs, G

Fertility Testing in Young Men After Successful Treatment of Hodgkin's Lymphoma with Procarbazine-Free Combination Regimen within the GPOH-HD 2002 Trial

Echevarría, A

Outcome of Spanish Patients outside Euronet-PHL-C1

Effinger, K

Longitudinal Evaluation of Health Status in Aging Pediatric Hodgkin Lymphoma Survivors: Report from the Childhood Cancer Survivor Study

Eggert, A

Feasibility of VECOPA a Dose-Intensive Regimen for Pediatric Intermediate and Advanced Stage Hodgkin's Lymphoma: Results of the GPOH-HD-2002/VECOPA-Pilot Study

Ehrlich, P

Treatment of Pediatric Lymphocyte Predominant Hodgkin Lymphoma (LPHL): A Report from the Children's Oncology Group

Eichenauer, D

Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD

Elenitoba-Johnson, K

Glycoproteomic Profiling of Hodgkin Lymphoma Reveals Novel Proteins that Contribute to the Microenvironment and Have Diagnostic Utility

Elia, C

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Role of Interim FDG-PET for Mediastinal Response Assessment in Pediatric Hodgkin's Lymphoma (HL):Preliminary Results from the Italian AIEOP-LH2004 Protocol

Escribano, A

Outcome of Spanish Patients outside Euronet-PHL-C1

Espadana, AI

Second Neoplasms in Adolescents and Young Adults with Hodgkin Lymphoma

Hodgkin Lymphoma in Adolescents and Young Adults: Comparing Outcomes

Evangelista, P

Retrospective Review of Bone Changes in Hodgkin Lymphoma utilizing CT, 18F FDG-PET, 99mTc-MDPbone Scan and MRI from Children's Oncology Group Intermediate Stage Protocol AHOD0031

Evans, N

10 Year Experience of a National Breast Screening Programme Following Radiotherapy for Hodgkin Lymphoma in South East Wales

Ewalt, M

Classical Hodgkin Lymphoma in Guatemalan Children of Age Less than Six Show High pPrevalence of EBV, HGAL and CD137: Prognostic and Therapeutic Implications

Facchetti, F

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T cell/Histiocyte Rich Large B Cell Lymphoma Endpoints of a Spectrum of one Disease?

Faizan, M

Challenges in Treating Hodgkin Lymphoma in a Developing Country: Children Hospital Lahore Experience

Falchook, G

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Falcon, D

BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela

Fanale, M

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Fanti, S

Role of Interim FDG-PET for Mediastinal Response Assessment in Pediatric Hodgkin's Lymphoma (HL):Preliminary Results from the Italian AIEOP-LH2004 Protocol

Farruggia, P

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Role of Interim FDG-PET for Mediastinal Response Assessment in Pediatric Hodgkin's Lymphoma (HL):Preliminary Results from the Italian AIEOP-LH2004 Protocol

Fasanmade, A

Phase 1/2 Study of Brentuximab Vedotin in Pediatric Pts with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 HL Data

Fayad, L

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Feller, A

Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD

Fend, F

MLL5 as Disease Contributing Gene in Classical Pediatric and Adult Hodgkin Lymphoma

Ferme, C

Combined Linkage and Association Studies of Antibodies against EBV Antigens Confirm the Role of HLA Class II Variants in the Control of Anti-EBNA1 IgG Levels and in the Risk of Hodgkin's Lymphoma

Fernández-Teijeiro, A

Outcome of Spanish Patients outside Euronet-PHL-C1

Fiedler, J

Cardiovascular Sequelae in Young Adult Survivors of Childhood Hodgkin Lymphoma

Fink, A

Social Inequalities in Participation and Activity in Children and Adolescents with Hodgkin's Lymphoma

Flamm, S

Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography (CCTA) in Adult Survivors of Childhood Hodgkin Lymphoma

Flampouri, S

Advancing the Therapeutic Index of Pediatric Patients with Stage III and IV Hodgkin Lymphoma with Proton Therapy

Fontoura, ML

A Dedicated Program for Young Adults who Suffer from Cancer: Experience of the Centre Henri Becquerel, Rouen, France

Franklin, ARK

Phase 1/2 Study of Brentuximab Vedotin in Pediatric Pts with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 HL Data

Freigeiro, D

Is it Possible to Work together in Latin America? Creation of a Latin American Consortium (CLEHOP)

Pediatric Hodgkin Lymphoma through Clinical Trials in Argentina in the Past 46 Years: The GATLA Experience

Friedman, D

Pleural Effusion in Intermediate Hodgkin Lymphoma COG Protocol AHOD0031-Evolution with Therapy and Association with Bulk Mediastinal Disease or Bone, Lung or Pleural Nodular Disease

Retrospective Review of Bone Changes in Hodgkin Lymphoma utilizing CT, 18F FDG-PET, 99mTc-MDPbone Scan and MRI from Children's Oncology Group Intermediate Stage Protocol AHOD0031

Frühwald, M

Feasibility of VECOPA a Dose-Intensive Regimen for Pediatric Intermediate and Advanced Stage Hodgkin's Lymphoma: Results of the GPOH-HD-2002/VECOPA-Pilot Study

Fukano, R

Pediatric Hodgkin's Lymphoma in Japan

Gallop-Evans, E

10 Year Experience of a National Breast Screening Programme Following Radiotherapy for Hodgkin Lymphoma in South East Wales

Gamboa, J

A Risk Adapted, Response- Based Therapeutic Regimen Using OEPA/COPDAC for the Treatment of Children with High Risk Hodgkin Lymphoma; from the Central American y Dominican Republic Group

Ganevová, M

Cardiovascular Sequelae in Young Adult Survivors of Childhood Hodgkin Lymphoma

Garaventa, A

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Role of Interim FDG-PET for Mediastinal Response Assessment in Pediatric Hodgkin's Lymphoma (HL):Preliminary Results from the Italian AIEOP-LH2004 Protocol

Garcia, J

Is it Possible to Work together in Latin America? Creation of a Latin American Consortium (CLEHOP)

García, M

Pediatric Hodgkin Lymphoma through Clinical Trials in Argentina in the Past 46 Years: The GATLA Experience

García Costa, A

Genetic Variants of Interleukin 10 (IL10) are Associated with Clinical Outcome and Tumor Microenvironment Composition of Classical Hodgkin Lymphoma (cHL)

Garcia Guevara, R

BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela

Garrido, C

Outcome of Spanish Patients outside Euronet-PHL-C1

Garrido-Laguna, I

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Gascoyne, R

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T cell/Histiocyte Rich Large B Cell Lymphoma Endpoints of a Spectrum of one Disease?

Gaspar, N

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

Georgi, T

Impact of Non-FDG-Avid Areas Inside a Tumour Mass in Paediatric Hodgkin Lymphoma (PHL) Patients

Geraldes, C

Second Neoplasms in Adolescents and Young Adults with Hodgkin Lymphoma

Hodgkin Lymphoma in Adolescents and Young Adults: Comparing Outcomes

Gilik, J

Cardiovascular Sequelae in Young Adult Survivors of Childhood Hodgkin Lymphoma

Giulino-Roth, L

Beta-2 Microglobulin (B2 M) Genomic Alterations and Absent Protein Expression in Pediatric and Adolescent Classical Hodgkin Lymphoma

Gomes, M

Second Neoplasms in Adolescents and Young Adults with Hodgkin Lymphoma

Hodgkin Lymphoma in Adolescents and Young Adults: Comparing Outcomes

Goode, V

The Breast Screening after Radiotherapy Dataset (BARD): a National Initiative to Optimise Screening for Breast cancer in Female Hodgkin Lymphoma Survivors in England

Goodman, P

The Evolution of Pediatric Hodgkin Lymphoma Therapy: Contemporary Protocols Significantly Reduce Radiation Exposure of Normal Tissues

Gorde-Grosjean, S

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

Gore, L

Phase 1/2 Study of Brentuximab Vedotin in Pediatric Pts with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 HL Data

Gower-Thomas, K

10 Year Experience of a National Breast Screening Programme Following Radiotherapy for Hodgkin Lymphoma in South East Wales

Große, I

Identification of Endogenous Retrovirus Sequences that are Associated with Hodgkin's Lymphoma Specific Gene Expression

Guergnon, J

Combined Linkage and Association Studies of Antibodies against EBV Antigens Confirm the Role of HLA Class II Variants in the Control of Anti-EBNA1 IgG Levels and in the Risk of Hodgkin's Lymphoma

Guerra, L

Role of Interim FDG-PET for Mediastinal Response Assessment in Pediatric Hodgkin's Lymphoma (HL):Preliminary Results from the Italian AIEOP-LH2004 Protocol

Guerrini, G

Hodgkin Lymphoma: 30-Year Experience. What is Changed?

Guibelalde, M

Outcome of Spanish Patients outside Euronet-PHL-C1

Guilherme, R

Second Neoplasms in Adolescents and Young Adults with Hodgkin Lymphoma

Hodgkin Lymphoma in Adolescents and Young Adults: Comparing Outcomes

Guillemet, C

A Dedicated Program for Young Adults who Suffer from Cancer: Experience of the Centre Henri Becquerel, Rouen, France

Gunma, K

Pediatric Hodgkin's Lymphoma in Japan

Hamdi, L

Hodgkin Lymphoma Subtypes and Peripheral B-cell Lymphopenia are Associated with EBV Status in Children and Adolescents in France: A Preliminary Report of the EuroNet LH EPI Project

Hansmann, ML

Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD

Re-fusion of Small Mononucleated Hodgkin Cells Leads to Multinucleated Reed-Sternberg Cells

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T cell/Histiocyte Rich Large B Cell Lymphoma Endpoints of a Spectrum of one Disease?

Haouy, S

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

Hartley, R

The Breast Screening after Radiotherapy Dataset (BARD): a National Initiative to Optimise Screening for Breast cancer in Female Hodgkin Lymphoma Survivors in England

Hartmann, S

Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD

Re-fusion of Small Mononucleated Hodgkin Cells Leads to Multinucleated Reed-Sternberg Cells

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T cell/Histiocyte Rich Large B Cell Lymphoma Endpoints of a Spectrum of one Disease?

Hasenclever, D

Impact of Non-FDG-Avid Areas Inside a Tumour Mass in Paediatric Hodgkin Lymphoma (PHL) Patients

Feasibility of VECOPA a Dose-Intensive Regimen for Pediatric Intermediate and Advanced Stage Hodgkin's Lymphoma: Results of the GPOH-HD-2002/VECOPA-Pilot Study

Outcome of Spanish Patients outside Euronet-PHL-C1

Hassan, R

M2 Macrophages but not M1 Macrophages Are Associated with Worst Outcome in Classical Hodgkin Lymphoma

Genetic Variants of Interleukin 10 (IL10) are Associated with Clinical Outcome and Tumor Microenvironment Composition of Classical Hodgkin Lymphoma (cHL)

PD1+ Cells in Pediatric Classical Hodgkin Lymphoma is Associated with Better Outcome

Hayward, J

Does Pathological Variability in Paediatric Nodular Lymphocyte Predominant Hodgkin Lymphoma Have Clinical Prognostic Significance?

Heinrich, T

Re-fusion of Small Mononucleated Hodgkin Cells Leads to Multinucleated Reed-Sternberg Cells

Helfre, S

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

Hepkema, B

HLA Associations in EBV Status Defined Subgroups of Classical Hodgkin Lymphoma

Hermine, O

Combined Linkage and Association Studies of Antibodies against EBV Antigens Confirm the Role of HLA Class II Variants in the Control of Anti-EBNA1 IgG Levels and in the Risk of Hodgkin's Lymphoma

HL-GATLA, CM

Pediatric Hodgkin Lymphoma through Clinical Trials in Argentina in the Past 46 Years: The GATLA Experience

Hodgson, D

The Evolution of Pediatric Hodgkin Lymphoma Therapy: Contemporary Protocols Significantly Reduce Radiation Exposure of Normal Tissues

Treatment of Pediatric Lymphocyte Predominant Hodgkin Lymphoma (LPHL): A Report from the Children's Oncology Group

Holtzman, A

Advancing the Therapeutic Index of Pediatric Patients with Stage III and IV Hodgkin Lymphoma with Proton Therapy

Holzendorf, V

Feasibility of VECOPA a Dose-Intensive Regimen for Pediatric Intermediate and Advanced Stage Hodgkin's Lymphoma: Results of the GPOH-HD-2002/VECOPA-Pilot Study

Hong, D

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Hoppe, B

Advancing the Therapeutic Index of Pediatric Patients with Stage III and IV Hodgkin Lymphoma with Proton Therapy

Variable Interpretations of Involved-Site Radiation Therapy Guidelines by Experienced Radiation Oncologists

Hoppe, R

Variable Interpretations of Involved-Site Radiation Therapy Guidelines by Experienced Radiation Oncologists

Howard, S

SIOP PODC Adapted Treatment Regimens for Hodgkin Lymphoma: A Framework for Management of Pediatric Cancer in Low- and Middle-income Countries

Howell, S

The Breast Screening after Radiotherapy Dataset (BARD): a National Initiative to Optimise Screening for Breast cancer in Female Hodgkin Lymphoma Survivors in England

Hudson, M

Longitudinal Evaluation of Health Status in Aging Pediatric Hodgkin Lymphoma Survivors: Report from the Childhood Cancer Survivor Study

Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography (CCTA) in Adult Survivors of Childhood Hodgkin Lymphoma

Hummel, M

Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD

Hutchison, R

Treatment of Pediatric Lymphocyte Predominant Hodgkin Lymphoma (LPHL): A Report from the Children's Oncology Group

Indolfi, P

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Role of Interim FDG-PET for Mediastinal Response Assessment in Pediatric Hodgkin's Lymphoma (HL):Preliminary Results from the Italian AIEOP-LH2004 Protocol

Işık, M

Evaluation of FDG-PET/CT and Conventional Imaging Techniques in Pediatric Hodgkin Lymphoma Patients in a Single Center

Clinical Characteristics and Outcome of Pediatric Patients with Relapsed or Refractory Hodgkin Lymphoma: Gazi University Pediatric Oncology Experience

Ivanova, M

Brentuximab Vedotin in Heavily Pretreated Patients with Refractory Hodgkin's Lymphoma

Jakobus, C

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T cell/Histiocyte Rich Large B Cell Lymphoma Endpoints of a Spectrum of one Disease?

Janik-Moszant, A

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Janku, F

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Jeon, YK

Glycoproteomic Profiling of Hodgkin Lymphoma Reveals Novel Proteins that Contribute to the Microenvironment and Have Diagnostic Utility

Jordan, C

10 Year Experience of a National Breast Screening Programme Following Radiotherapy for Hodgkin Lymphoma in South East Wales

Joshi, V

Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography (CCTA) in Adult Survivors of Childhood Hodgkin Lymphoma

Joyce, M

Advancing the Therapeutic Index of Pediatric Patients with Stage III and IV Hodgkin Lymphoma with Proton Therapy

Jürgens, H

Fertility Testing in Young Men After Successful Treatment of Hodgkin's Lymphoma with Procarbazine-Free Combination Regimen within the GPOH-HD 2002 Trial

Feasibility of VECOPA a Dose-Intensive Regimen for Pediatric Intermediate and Advanced Stage Hodgkin's Lymphoma: Results of the GPOH-HD-2002/VECOPA-Pilot Study

Kabickova, E

Cardiovascular Sequelae in Young Adult Survivors of Childhood Hodgkin Lymphoma

Kamienska, E

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Kapucu, O

Evaluation of FDG-PET/CT and Conventional Imaging Techniques in Pediatric Hodgkin Lymphoma Patients in a Single Center

Karadeniz, C

Evaluation of FDG-PET/CT and Conventional Imaging Techniques in Pediatric Hodgkin Lymphoma Patients in a Single Center

Clinical Characteristics and Outcome of Pediatric Patients with Relapsed or Refractory Hodgkin Lymphoma: Gazi University Pediatric Oncology Experience

Karhan, A

Treatment Results of 102 Patients with Hodgkin Lymphoma under 5 Years of Age

Karolczyk, G

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Kataru, SR

Hodgkin's Lymphoma-Eight Year Experience of a Tertiary Care Center in South India

Kazantsev, I

Brentuximab Vedotin in Heavily Pretreated Patients with Refractory Hodgkin's Lymphoma

Keller, F

Outcomes and Patterns of Failure in Children/Adolescents with Low Risk Hodgkin Lymphoma (HL) who Are FDG-PET (PET3) Positive after AVPC Therapy

Intensive Therapy Free Survival (ITFS) for Early-Stage Hodgkin Lymphoma (cHL) Including Chemotherapy and Radiation Therapy (IFRT) for Recurrence after Chemotherapy alone

Kewitz, S

Cancer/Testis Antigen 96 (Dual Specificity Protein Kinase TTK) is an Interesting Target for Hodgkin's Lymphoma

Identification of Endogenous Retrovirus Sequences that are Associated with Hodgkin's Lymphoma Specific Gene Expression

Hodgkin's Lymphoma Specific Transcripts and Minimal Residual Disease Detection

O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and resistance of Hodgkin's Lymphoma Cells against Dacarbazine

Khalifa, N

PET Based Response Adapted Treatment in Pediatric HD Can Significantly Reduce Use of Radiation Therapy: A Study from Kuwait Cancer Control Centre, Kuwait

Khalifa, S

PET Based Response Adapted Treatment in Pediatric HD Can Significantly Reduce Use of Radiation Therapy: A Study from Kuwait Cancer Control Centre, Kuwait

Khan, S

Refractory or Relapsed Hodgkin's Lymphoma Treated with High Dose Chemotherapy Followed by Autologous Stem Cell Transplantation: Experience at SKMCH Lahore

Kielholz, L

Identification of Endogenous Retrovirus Sequences that are Associated with Hodgkin's Lymphoma Specific Gene Expression

Kikuchi, A

Pediatric Hodgkin's Lymphoma in Japan

Kirchberger, D

MLL5 as Disease Contributing Gene in Classical Pediatric and Adult Hodgkin Lymphoma

Klapper, W

Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD

Grey Zone Lymphoma in Children and Adolescents: Experience of Pediatric Hodgkin and Non-Hodgkin Study Groups

Klein, C

MLL5 as Disease Contributing Gene in Classical Pediatric and Adult Hodgkin Lymphoma

Klekawka, T

Immunological Status of the Host in Aspect of Epstein-Barr Virus Latency in Pediatric Hodgkin Lymphoma

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Klingebiel, T

Feasibility of VECOPA a Dose-Intensive Regimen for Pediatric Intermediate and Advanced Stage Hodgkin's Lymphoma: Results of the GPOH-HD-2002/VECOPA-Pilot Study

Kluge, R

Impact of Non-FDG-Avid Areas Inside a Tumour Mass in Paediatric Hodgkin Lymphoma (PHL) Patients

Kluiver, J

Long Non-Coding RNAs Are Commonly Deregulated in Hodgkin Lymphoma

Kobayashi, R

Pediatric Hodgkin's Lymphoma in Japan

Koch, K

Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD

Koga, Y

Pediatric Hodgkin's Lymphoma in Japan

Kok, K

Long Non-Coding RNAs Are Commonly Deregulated in Hodgkin Lymphoma

Koltan, A

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Kondakova, E

Brentuximab Vedotin in Heavily Pretreated Patients with Refractory Hodgkin's Lymphoma

Konovalov, D

Treatment of Children and Adolescents with Hodgkin's Lymphoma According to Recommendations of DAL/GPOH-HD Group (Preliminary Results)

Körholz, D

Social Inequalities in Participation and Activity in Children and Adolescents with Hodgkin's Lymphoma

Fertility Testing in Young Men After Successful Treatment of Hodgkin's Lymphoma with Procarbazine-Free Combination Regimen within the GPOH-HD 2002 Trial

Impact of Non-FDG-Avid Areas Inside a Tumour Mass in Paediatric Hodgkin Lymphoma (PHL) Patients

Hodgkin's Lymphoma Specific Transcripts and Minimal Residual Disease Detection

Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD

Feasibility of VECOPA a Dose-Intensive Regimen for Pediatric Intermediate and Advanced Stage Hodgkin's Lymphoma: Results of the GPOH-HD-2002/VECOPA-Pilot Study

Grey Zone Lymphoma in Children and Adolescents: Experience of Pediatric Hodgkin and Non-Hodgkin Study Groups

Kortman, G

Long Non-Coding RNAs Are Commonly Deregulated in Hodgkin Lymphoma

Kouprie, N

HLA Associations in EBV Status Defined Subgroups of Classical Hodgkin Lymphoma

Kowalczyk, J

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Kramm, C

Fertility Testing in Young Men After Successful Treatment of Hodgkin's Lymphoma with Procarbazine-Free Combination Regimen within the GPOH-HD 2002 Trial

O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and resistance of Hodgkin's Lymphoma Cells against Dacarbazine

Krasin, M

Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography (CCTA) in Adult Survivors of Childhood Hodgkin Lymphoma

Krawczuk-Rybak, M

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Kremer, M

MLL5 as Disease Contributing Gene in Classical Pediatric and Adult Hodgkin Lymphoma

Kruse, K

Identification of Endogenous Retrovirus Sequences that are Associated with Hodgkin's Lymphoma Specific Gene Expression

Kruseova, J

Cardiovascular Sequelae in Young Adult Survivors of Childhood Hodgkin Lymphoma

Krziesek, R

Hodgkin Lymphoma Subtypes and Peripheral B-cell Lymphopenia are Associated with EBV Status in Children and Adolescents in France: A Preliminary Report of the EuroNet LH EPI Project

Küppers, R

Re-fusion of Small Mononucleated Hodgkin Cells Leads to Multinucleated Reed-Sternberg Cells

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T cell/Histiocyte Rich Large B Cell Lymphoma Endpoints of a Spectrum of one Disease?

Kurch, L

Impact of Non-FDG-Avid Areas Inside a Tumour Mass in Paediatric Hodgkin Lymphoma (PHL) Patients

Kurzrock, R

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Kushekhar, K

HLA Associations in EBV Status Defined Subgroups of Classical Hodgkin Lymphoma

Kutluk, T

Treatment Results of 102 Patients with Hodgkin Lymphoma under 5 Years of Age

Kwak, L

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Lakkaraju, VV

Hodgkin's Lymphoma-Eight Year Experience of a Tertiary Care Center in South India

Lambilliote, A

Hodgkin Lymphoma Subtypes and Peripheral B-cell Lymphopenia are Associated with EBV Status in Children and Adolescents in France: A Preliminary Report of the EuroNet LH EPI Project

Lambilliotte, A

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

Landman-Parker, J

Hodgkin Lymphoma Subtypes and Peripheral B-cell Lymphopenia are Associated with EBV Status in Children and Adolescents in France: A Preliminary Report of the EuroNet LH EPI Project

Phase 1/2 Study of Brentuximab Vedotin in Pediatric Pts with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 HL Data

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

Lang, W

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

La Spina, M

Immune Thrombocytopenia at Diagnosis of Hodgkin Lymphoma

Lastiri, F

Pediatric Hodgkin Lymphoma through Clinical Trials in Argentina in the Past 46 Years: The GATLA Experience

Leblanc, T

Hodgkin Lymphoma Subtypes and Peripheral B-cell Lymphopenia are Associated with EBV Status in Children and Adolescents in France: A Preliminary Report of the EuroNet LH EPI Project

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

Lederman, HM

The Use of DWI WB-MRI in Pediatric Oncology, a Single Institution Experience and Pictorial Essay

Lee, C

A Dedicated Program for Young Adults who Suffer from Cancer: Experience of the Centre Henri Becquerel, Rouen, France

Leisenring, W

Longitudinal Evaluation of Health Status in Aging Pediatric Hodgkin Lymphoma Survivors: Report from the Childhood Cancer Survivor Study

The Evolution of Pediatric Hodgkin Lymphoma Therapy: Contemporary Protocols Significantly Reduce Radiation Exposure of Normal Tissues

Le Pendeven, C

Combined Linkage and Association Studies of Antibodies against EBV Antigens Confirm the Role of HLA Class II Variants in the Control of Anti-EBNA1 IgG Levels and in the Risk of Hodgkin's Lymphoma

Lewis, J

Definition and Significance of Osseous Involvement in Newly Diagnosed Pediatric Hodgkin Lymphoma

Li, RC

Treatment Outcome of a Multi-Centre Clinical Study of Hodgkin Lymphoma: A Report by Hong Kong Paediatric Haematology and Oncology Study Group

Li, Z

Advancing the Therapeutic Index of Pediatric Patients with Stage III and IV Hodgkin Lymphoma with Proton Therapy

Lim, M

Glycoproteomic Profiling of Hodgkin Lymphoma Reveals Novel Proteins that Contribute to the Microenvironment and Have Diagnostic Utility

Ling, S

Treatment Outcome of a Multi-Centre Clinical Study of Hodgkin Lymphoma: A Report by Hong Kong Paediatric Haematology and Oncology Study Group

Locatelli, F

Phase 1/2 Study of Brentuximab Vedotin in Pediatric Pts with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 HL Data

Lopci, E

Role of Interim FDG-PET for Mediastinal Response Assessment in Pediatric Hodgkin's Lymphoma (HL):Preliminary Results from the Italian AIEOP-LH2004 Protocol

Lüders, H

Subsequent Malignant Neoplasms in Survivors of Pediatric DAL/GPOH-Hodgkin-Lymphoma Trials

Luks, A

Cardiovascular Sequelae in Young Adult Survivors of Childhood Hodgkin Lymphoma

Luna-Feinman, S

Classical Hodgkin Lymphoma in Guatemalan Children of Age Less than Six Show High pPrevalence of EBV, HGAL and CD137: Prognostic and Therapeutic Implications

Luz, B

Second Neoplasms in Adolescents and Young Adults with Hodgkin Lymphoma

Hodgkin Lymphoma in Adolescents and Young Adults: Comparing Outcomes

Magalhães, E

Second Neoplasms in Adolescents and Young Adults with Hodgkin Lymphoma

Hodgkin Lymphoma in Adolescents and Young Adults: Comparing Outcomes

Magro, G

Immune Thrombocytopenia at Diagnosis of Hodgkin Lymphoma

Malek, A

Results of Thyroid Function Assessment in Children and Adolescents with Hodgkin's Lymphoma Treated According to HD-97 Protocol

Assessment of Gonadal Function in Young Men Treated for Hodgkin's Lymphoma during Childhood and Adolescence

Malinowska, I

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Malis, J

Cardiovascular Sequelae in Young Adult Survivors of Childhood Hodgkin Lymphoma

Maneck, M

MLL5 as Disease Contributing Gene in Classical Pediatric and Adult Hodgkin Lymphoma

Manickavasagam, M

Hodgkin's Lymphoma-Eight Year Experience of a Tertiary Care Center in South India

Manzo, E

Clinical and Treatment Results of a Group of Children Diagnosed with Hodgkin Lymphoma in a Single Brazilian Institution

Marina, N

Longitudinal Evaluation of Health Status in Aging Pediatric Hodgkin Lymphoma Survivors: Report from the Childhood Cancer Survivor Study

Marino, S

Immune Thrombocytopenia at Diagnosis of Hodgkin Lymphoma

Martina, M

Hodgkin Lymphoma: 30-Year Experience. What is Changed?

Marval, M

BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela

Mascarin, M

Risk assessment of Solid Secondary Malignancies (SMN) in Childhood and Adolescent Hodgkin Lymphoma (HL) Treated with Radiotherapy (RT): Conventional RT vs. Helical Tomotherapy

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Role of Interim FDG-PET for Mediastinal Response Assessment in Pediatric Hodgkin's Lymphoma (HL):Preliminary Results from the Italian AIEOP-LH2004 Protocol

Matysiak, M

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Mauad, MA

Clinical and Treatment Results of a Group of Children Diagnosed with Hodgkin Lymphoma in a Single Brazilian Institution

Mauz-Körholz, C

Social Inequalities in Participation and Activity in Children and Adolescents with Hodgkin's Lymphoma

Fertility Testing in Young Men After Successful Treatment of Hodgkin's Lymphoma with Procarbazine-Free Combination Regimen within the GPOH-HD 2002 Trial

Impact of Non-FDG-Avid Areas Inside a Tumour Mass in Paediatric Hodgkin Lymphoma (PHL) Patients

Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD

Feasibility of VECOPA a Dose-Intensive Regimen for Pediatric Intermediate and Advanced Stage Hodgkin's Lymphoma: Results of the GPOH-HD-2002/VECOPA-Pilot Study

Phase 1/2 Study of Brentuximab Vedotin in Pediatric Pts with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 HL Data

Grey Zone Lymphoma in Children and Adolescents: Experience of Pediatric Hodgkin and Non-Hodgkin Study Groups

McCarten, K

Definition and Significance of Osseous Involvement in Newly Diagnosed Pediatric Hodgkin Lymphoma

Pleural Effusion in Intermediate Hodgkin Lymphoma COG Protocol AHOD0031-Evolution with Therapy and Association with Bulk Mediastinal Disease or Bone, Lung or Pleural Nodular Disease

Retrospective Review of Bone Changes in Hodgkin Lymphoma utilizing CT, 18F FDG-PET, 99mTc-MDPbone Scan and MRI from Children's Oncology Group Intermediate Stage Protocol AHOD0031

Outcomes and Patterns of Failure in Children/Adolescents with Low Risk Hodgkin Lymphoma (HL) who Are FDG-PET (PET3) Positive after AVPC Therapy

Intensive Therapy Free Survival (ITFS) for Early-Stage Hodgkin Lymphoma (cHL) Including Chemotherapy and Radiation Therapy (IFRT) for Recurrence after Chemotherapy alone

McDonald, A

The Evolution of Pediatric Hodgkin Lymphoma Therapy: Contemporary Protocols Significantly Reduce Radiation Exposure of Normal Tissues

Mejias, M

BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela

Meli, M

Immune Thrombocytopenia at Diagnosis of Hodgkin Lymphoma

Mendenhall, N

Advancing the Therapeutic Index of Pediatric Patients with Stage III and IV Hodgkin Lymphoma with Proton Therapy

Mendoza, C

BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela

Meric-Bernstam, F

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Metcalf, R

Classical Hodgkin Lymphoma in Guatemalan Children of Age Less than Six Show High pPrevalence of EBV, HGAL and CD137: Prognostic and Therapeutic Implications

Metzger, M

Definition and Significance of Osseous Involvement in Newly Diagnosed Pediatric Hodgkin Lymphoma

Pleural Effusion in Intermediate Hodgkin Lymphoma COG Protocol AHOD0031-Evolution with Therapy and Association with Bulk Mediastinal Disease or Bone, Lung or Pleural Nodular Disease

Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography (CCTA) in Adult Survivors of Childhood Hodgkin Lymphoma

A Risk Adapted, Response- Based Therapeutic Regimen Using OEPA/COPDAC for the Treatment of Children with High Risk Hodgkin Lymphoma; from the Central American y Dominican Republic Group

SIOP PODC Adapted Treatment Regimens for Hodgkin Lymphoma: A Framework for Management of Pediatric Cancer in Low- and Middle-income Countries

Metzler, M

Feasibility of VECOPA a Dose-Intensive Regimen for Pediatric Intermediate and Advanced Stage Hodgkin's Lymphoma: Results of the GPOH-HD-2002/VECOPA-Pilot Study

Mikhailova, N

Brentuximab Vedotin in Heavily Pretreated Patients with Refractory Hodgkin's Lymphoma

Mitsui, T

Pediatric Hodgkin's Lymphoma in Japan

Mittal, R

PET Based Response Adapted Treatment in Pediatric HD Can Significantly Reduce Use of Radiation Therapy: A Study from Kuwait Cancer Control Centre, Kuwait

Mitura-Lesiuk, M

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Mlynarski, W

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Moiseev, I

Brentuximab Vedotin in Heavily Pretreated Patients with Refractory Hodgkin's Lymphoma

Moleti, ML

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Role of Interim FDG-PET for Mediastinal Response Assessment in Pediatric Hodgkin's Lymphoma (HL):Preliminary Results from the Italian AIEOP-LH2004 Protocol

Möller, P

Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD

Mollweide, A

MLL5 as Disease Contributing Gene in Classical Pediatric and Adult Hodgkin Lymphoma

Montero, E

BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela

Montilva, R

BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela

Mori, T

Pediatric Hodgkin's Lymphoma in Japan

Pediatric Hodgkin's Lymphoma in Japan

Moryl-Bujakowska, A

Results of Thyroid Function Assessment in Children and Adolescents with Hodgkin's Lymphoma Treated According to HD-97 Protocol

Assessment of Gonadal Function in Young Men Treated for Hodgkin's Lymphoma during Childhood and Adolescence

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Moscheo, C

Immune Thrombocytopenia at Diagnosis of Hodgkin Lymphoma

Mottok, A

Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD

Muhammad, S

Hodgkin Disease in Pakistani Children: Outcome with Treatment Primarily Based on Chemotherapy with ABVD/COPDAC and Radiotherapy for Residual Disease

Müller, H

Feasibility of VECOPA a Dose-Intensive Regimen for Pediatric Intermediate and Advanced Stage Hodgkin's Lymphoma: Results of the GPOH-HD-2002/VECOPA-Pilot Study

Mulrooney, D

Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography (CCTA) in Adult Survivors of Childhood Hodgkin Lymphoma

Murgia, G

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Muszynska-Roslan, K

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Myakova, N

Treatment of Children and Adolescents with Hodgkin's Lymphoma According to Recommendations of DAL/GPOH-HD Group (Preliminary Results)

Nardi, M

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Natkunam, Y

Classical Hodgkin Lymphoma in Guatemalan Children of Age Less than Six Show High pPrevalence of EBV, HGAL and CD137: Prognostic and Therapeutic Implications

Naz, F

Hodgkin Disease in Pakistani Children: Outcome with Treatment Primarily Based on Chemotherapy with ABVD/COPDAC and Radiotherapy for Residual Disease

Nechesnyuk, A

Treatment of Children and Adolescents with Hodgkin's Lymphoma According to Recommendations of DAL/GPOH-HD Group (Preliminary Results)

Neelapu, S

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Ness, K

Longitudinal Evaluation of Health Status in Aging Pediatric Hodgkin Lymphoma Survivors: Report from the Childhood Cancer Survivor Study

Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography (CCTA) in Adult Survivors of Childhood Hodgkin Lymphoma

Neville, K

Phase 1/2 Study of Brentuximab Vedotin in Pediatric Pts with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 HL Data

Newrzela, S

Re-fusion of Small Mononucleated Hodgkin Cells Leads to Multinucleated Reed-Sternberg Cells

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T cell/Histiocyte Rich Large B Cell Lymphoma Endpoints of a Spectrum of one Disease?

Ng, A

The Evolution of Pediatric Hodgkin Lymphoma Therapy: Contemporary Protocols Significantly Reduce Radiation Exposure of Normal Tissues

Niedobitek, G

M2 Macrophages but not M1 Macrophages Are Associated with Worst Outcome in Classical Hodgkin Lymphoma

PD1+ Cells in Pediatric Classical Hodgkin Lymphoma is Associated with Better Outcome

Nolte, I

HLA Associations in EBV Status Defined Subgroups of Classical Hodgkin Lymphoma

Nunez, C

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Nunnery, S

Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography (CCTA) in Adult Survivors of Childhood Hodgkin Lymphoma

O'Hara, C

The Breast Screening after Radiotherapy Dataset (BARD): a National Initiative to Optimise Screening for Breast cancer in Female Hodgkin Lymphoma Survivors in England

Oeffinger, K

Longitudinal Evaluation of Health Status in Aging Pediatric Hodgkin Lymphoma Survivors: Report from the Childhood Cancer Survivor Study

Oguz, A

Evaluation of FDG-PET/CT and Conventional Imaging Techniques in Pediatric Hodgkin Lymphoma Patients in a Single Center

Oğuz, A

Clinical Characteristics and Outcome of Pediatric Patients with Relapsed or Refractory Hodgkin Lymphoma: Gazi University Pediatric Oncology Experience

Oki, Y

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Okur, A

Evaluation of FDG-PET/CT and Conventional Imaging Techniques in Pediatric Hodgkin Lymphoma Patients in a Single Center

Clinical Characteristics and Outcome of Pediatric Patients with Relapsed or Refractory Hodgkin Lymphoma: Gazi University Pediatric Oncology Experience

Oliveira, CT

Clinical and Treatment Results of a Group of Children Diagnosed with Hodgkin Lymphoma in a Single Brazilian Institution

Osumi, T

Pediatric Hodgkin's Lymphoma in Japan

Ott, G

Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD

Ozdemir, S

Advancing the Therapeutic Index of Pediatric Patients with Stage III and IV Hodgkin Lymphoma with Proton Therapy

Pachano, S

BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela

Pacquement, H

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

Paez, A

BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela

Parkhomenko, R

Treatment of Children and Adolescents with Hodgkin's Lymphoma According to Recommendations of DAL/GPOH-HD Group (Preliminary Results)

Paulo, J

Second Neoplasms in Adolescents and Young Adults with Hodgkin Lymphoma

Hodgkin Lymphoma in Adolescents and Young Adults: Comparing Outcomes

Pavlovsky, S

Pediatric Hodgkin Lymphoma through Clinical Trials in Argentina in the Past 46 Years: The GATLA Experience

Pedergnana, V

Combined Linkage and Association Studies of Antibodies against EBV Antigens Confirm the Role of HLA Class II Variants in the Control of Anti-EBNA1 IgG Levels and in the Risk of Hodgkin's Lymphoma

Pelz, T

Impact of Non-FDG-Avid Areas Inside a Tumour Mass in Paediatric Hodgkin Lymphoma (PHL) Patients

Peña, A

A Risk Adapted, Response- Based Therapeutic Regimen Using OEPA/COPDAC for the Treatment of Children with High Risk Hodgkin Lymphoma; from the Central American y Dominican Republic Group

Piatek, T

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Piccardo, A

Role of Interim FDG-PET for Mediastinal Response Assessment in Pediatric Hodgkin's Lymphoma (HL):Preliminary Results from the Italian AIEOP-LH2004 Protocol

Pierani, P

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Pinarli, FG

Evaluation of FDG-PET/CT and Conventional Imaging Techniques in Pediatric Hodgkin Lymphoma Patients in a Single Center

Plat, G

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

Plattel, WJ

Comparison of Serial Plasma Galectin-1, sCD163 and sCD30 with Plasma TARC Levels as Circulating Biomarkers for Response Evaluation in Classical Hodgkin Lymphoma

Ponomareva, N

Treatment of Children and Adolescents with Hodgkin's Lymphoma According to Recommendations of DAL/GPOH-HD Group (Preliminary Results)

Ponzoni, M

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T cell/Histiocyte Rich Large B Cell Lymphoma Endpoints of a Spectrum of one Disease?

Poppema, S

HLA Associations in EBV Status Defined Subgroups of Classical Hodgkin Lymphoma

Porta, F

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Prader, S

Palliative Irradiation in a Primary Refractory Hodgkin Lymphoma Patient

Pınarlı, FG

Clinical Characteristics and Outcome of Pediatric Patients with Relapsed or Refractory Hodgkin Lymphoma: Gazi University Pediatric Oncology Experience

Radford, J

The Breast Screening after Radiotherapy Dataset (BARD): a National Initiative to Optimise Screening for Breast cancer in Female Hodgkin Lymphoma Survivors in England

Ramsay, A

Does Pathological Variability in Paediatric Nodular Lymphocyte Predominant Hodgkin Lymphoma Have Clinical Prognostic Significance?

Rasheed, A

Refractory or Relapsed Hodgkin's Lymphoma Treated with High Dose Chemotherapy Followed by Autologous Stem Cell Transplantation: Experience at SKMCH Lahore

Reguerre, Y

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

Reichel, J

Beta-2 Microglobulin (B2 M) Genomic Alterations and Absent Protein Expression in Pediatric and Adolescent Classical Hodgkin Lymphoma

Rengstl, B

Re-fusion of Small Mononucleated Hodgkin Cells Leads to Multinucleated Reed-Sternberg Cells

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T cell/Histiocyte Rich Large B Cell Lymphoma Endpoints of a Spectrum of one Disease?

Riaz, S

Refractory or Relapsed Hodgkin's Lymphoma Treated with High Dose Chemotherapy Followed by Autologous Stem Cell Transplantation: Experience at SKMCH Lahore

Ribeiro, L

Second Neoplasms in Adolescents and Young Adults with Hodgkin Lymphoma

Hodgkin Lymphoma in Adolescents and Young Adults: Comparing Outcomes

Richter, G

MLL5 as Disease Contributing Gene in Classical Pediatric and Adult Hodgkin Lymphoma

Richter, M

Social Inequalities in Participation and Activity in Children and Adolescents with Hodgkin's Lymphoma

Rieger, MA

Re-fusion of Small Mononucleated Hodgkin Cells Leads to Multinucleated Reed-Sternberg Cells

Riepenhausen, M

Subsequent Malignant Neoplasms in Survivors of Pediatric DAL/GPOH-Hodgkin-Lymphoma Trials

Rigal, O

A Dedicated Program for Young Adults who Suffer from Cancer: Experience of the Centre Henri Becquerel, Rouen, France

Rinieri, S

Hodgkin Lymphoma: 30-Year Experience. What is Changed?

Rischewski, J

Palliative Irradiation in a Primary Refractory Hodgkin Lymphoma Patient

Rito, L

Second Neoplasms in Adolescents and Young Adults with Hodgkin Lymphoma

Hodgkin Lymphoma in Adolescents and Young Adults: Comparing Outcomes

Rivero, M

BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela

Robison, L

Longitudinal Evaluation of Health Status in Aging Pediatric Hodgkin Lymphoma Survivors: Report from the Childhood Cancer Survivor Study

Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography (CCTA) in Adult Survivors of Childhood Hodgkin Lymphoma

The Evolution of Pediatric Hodgkin Lymphoma Therapy: Contemporary Protocols Significantly Reduce Radiation Exposure of Normal Tissues

Rodriguez, I

Outcome of Spanish Patients outside Euronet-PHL-C1

Rogozhin, D

Treatment of Children and Adolescents with Hodgkin's Lymphoma According to Recommendations of DAL/GPOH-HD Group (Preliminary Results)

Rojas, N

BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela

Rolland, D

Glycoproteomic Profiling of Hodgkin Lymphoma Reveals Novel Proteins that Contribute to the Microenvironment and Have Diagnostic Utility

Rondelli, R

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Rosenwald, A

Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD

Roshal, M

Beta-2 Microglobulin (B2 M) Genomic Alterations and Absent Protein Expression in Pediatric and Adolescent Classical Hodgkin Lymphoma

Rosolen, A

Risk assessment of Solid Secondary Malignancies (SMN) in Childhood and Adolescent Hodgkin Lymphoma (HL) Treated with Radiotherapy (RT): Conventional RT vs. Helical Tomotherapy

Phase 1/2 Study of Brentuximab Vedotin in Pediatric Pts with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 HL Data

Ruch, MM

Identification of Endogenous Retrovirus Sequences that are Associated with Hodgkin's Lymphoma Specific Gene Expression

Rudneva, A

Treatment of Children and Adolescents with Hodgkin's Lymphoma According to Recommendations of DAL/GPOH-HD Group (Preliminary Results)

Russo, G

Immune Thrombocytopenia at Diagnosis of Hodgkin Lymphoma

Ryskal', O

Treatment of Children and Adolescents with Hodgkin's Lymphoma According to Recommendations of DAL/GPOH-HD Group (Preliminary Results)

Sabri, O

Impact of Non-FDG-Avid Areas Inside a Tumour Mass in Paediatric Hodgkin Lymphoma (PHL) Patients

Sachs, J

Phase 1/2 Study of Brentuximab Vedotin in Pediatric Pts with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 HL Data

Sagaert, X

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T cell/Histiocyte Rich Large B Cell Lymphoma Endpoints of a Spectrum of one Disease?

Sainani, K

Longitudinal Evaluation of Health Status in Aging Pediatric Hodgkin Lymphoma Survivors: Report from the Childhood Cancer Survivor Study

Sala, A

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Role of Interim FDG-PET for Mediastinal Response Assessment in Pediatric Hodgkin's Lymphoma (HL):Preliminary Results from the Italian AIEOP-LH2004 Protocol

Salhia, B

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Samochatova, E

Treatment of Children and Adolescents with Hodgkin's Lymphoma According to Recommendations of DAL/GPOH-HD Group (Preliminary Results)

Sandler, E

Advancing the Therapeutic Index of Pediatric Patients with Stage III and IV Hodgkin Lymphoma with Proton Therapy

Santoro, N

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Santos, M

Second Neoplasms in Adolescents and Young Adults with Hodgkin Lymphoma

Hodgkin Lymphoma in Adolescents and Young Adults: Comparing Outcomes

Sarache, C

BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela

Schätzle, S

Palliative Irradiation in a Primary Refractory Hodgkin Lymphoma Patient

Schell, M

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

Schellong, G

Subsequent Malignant Neoplasms in Survivors of Pediatric DAL/GPOH-Hodgkin-Lymphoma Trials

Schiavon, JL

The Use of DWI WB-MRI in Pediatric Oncology, a Single Institution Experience and Pictorial Essay

Schmid, F

Re-fusion of Small Mononucleated Hodgkin Cells Leads to Multinucleated Reed-Sternberg Cells

Schmitt, C

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

Schneppenheim, R

Fertility Testing in Young Men After Successful Treatment of Hodgkin's Lymphoma with Procarbazine-Free Combination Regimen within the GPOH-HD 2002 Trial

Schroeder, T

Re-fusion of Small Mononucleated Hodgkin Cells Leads to Multinucleated Reed-Sternberg Cells

Schvartzman, E

Pediatric Hodgkin Lymphoma through Clinical Trials in Argentina in the Past 46 Years: The GATLA Experience

Schwartz, C

Pleural Effusion in Intermediate Hodgkin Lymphoma COG Protocol AHOD0031-Evolution with Therapy and Association with Bulk Mediastinal Disease or Bone, Lung or Pleural Nodular Disease

Retrospective Review of Bone Changes in Hodgkin Lymphoma utilizing CT, 18F FDG-PET, 99mTc-MDPbone Scan and MRI from Children's Oncology Group Intermediate Stage Protocol AHOD0031

Treatment of Pediatric Lymphocyte Predominant Hodgkin Lymphoma (LPHL): A Report from the Children's Oncology Group

Outcomes and Patterns of Failure in Children/Adolescents with Low Risk Hodgkin Lymphoma (HL) who Are FDG-PET (PET3) Positive after AVPC Therapy

Intensive Therapy Free Survival (ITFS) for Early-Stage Hodgkin Lymphoma (cHL) Including Chemotherapy and Radiation Therapy (IFRT) for Recurrence after Chemotherapy alone

Segges, P

M2 Macrophages but not M1 Macrophages Are Associated with Worst Outcome in Classical Hodgkin Lymphoma

PD1+ Cells in Pediatric Classical Hodgkin Lymphoma is Associated with Better Outcome

Sekimizu, M

Pediatric Hodgkin's Lymphoma in Japan

Seror, E

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

Shankar, A

Does Pathological Variability in Paediatric Nodular Lymphocyte Predominant Hodgkin Lymphoma Have Clinical Prognostic Significance?

Shing, MMK

Treatment Outcome of a Multi-Centre Clinical Study of Hodgkin Lymphoma: A Report by Hong Kong Paediatric Haematology and Oncology Study Group

Shpall, E

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Sietzema, J

Long Non-Coding RNAs Are Commonly Deregulated in Hodgkin Lymphoma

Slayton, W

Advancing the Therapeutic Index of Pediatric Patients with Stage III and IV Hodgkin Lymphoma with Proton Therapy

Smirnova, N

Treatment of Children and Adolescents with Hodgkin's Lymphoma According to Recommendations of DAL/GPOH-HD Group (Preliminary Results)

Sobol, G

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Spoor, W

The Breast Screening after Radiotherapy Dataset (BARD): a National Initiative to Optimise Screening for Breast cancer in Female Hodgkin Lymphoma Survivors in England

Srivastava, K

Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography (CCTA) in Adult Survivors of Childhood Hodgkin Lymphoma

Stachowicz-Stencel, T

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Staege, MS

Cancer/Testis Antigen 96 (Dual Specificity Protein Kinase TTK) is an Interesting Target for Hodgkin's Lymphoma

Identification of Endogenous Retrovirus Sequences that are Associated with Hodgkin's Lymphoma Specific Gene Expression

Hodgkin's Lymphoma Specific Transcripts and Minimal Residual Disease Detection

O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and resistance of Hodgkin's Lymphoma Cells against Dacarbazine

Stamatoullas, A

A Dedicated Program for Young Adults who Suffer from Cancer: Experience of the Centre Henri Becquerel, Rouen, France

Steidl, C

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T cell/Histiocyte Rich Large B Cell Lymphoma Endpoints of a Spectrum of one Disease?

Stein, H

Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD

Stiefel, M

Fertility Testing in Young Men After Successful Treatment of Hodgkin's Lymphoma with Procarbazine-Free Combination Regimen within the GPOH-HD 2002 Trial

Stoevesandt, D

Impact of Non-FDG-Avid Areas Inside a Tumour Mass in Paediatric Hodgkin Lymphoma (PHL) Patients

Stolarska, M

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Stovall, M

Longitudinal Evaluation of Health Status in Aging Pediatric Hodgkin Lymphoma Survivors: Report from the Childhood Cancer Survivor Study

The Evolution of Pediatric Hodgkin Lymphoma Therapy: Contemporary Protocols Significantly Reduce Radiation Exposure of Normal Tissues

Streitenberger, P

Pediatric Hodgkin Lymphoma through Clinical Trials in Argentina in the Past 46 Years: The GATLA Experience

Streneva, O

Treatment of Children and Adolescents with Hodgkin's Lymphoma According to Recommendations of DAL/GPOH-HD Group (Preliminary Results)

Su, Z

Advancing the Therapeutic Index of Pediatric Patients with Stage III and IV Hodgkin Lymphoma with Proton Therapy

Subbiah, V

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Sunami, S

Pediatric Hodgkin's Lymphoma in Japan

Super, L

Hodgkin Lymphoma in Children: Experience in Australia

Swerdlow, A

The Breast Screening after Radiotherapy Dataset (BARD): a National Initiative to Optimise Screening for Breast cancer in Female Hodgkin Lymphoma Survivors in England

Syx, L

Combined Linkage and Association Studies of Antibodies against EBV Antigens Confirm the Role of HLA Class II Variants in the Control of Anti-EBNA1 IgG Levels and in the Risk of Hodgkin's Lymphoma

Szczepanski, T

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Sztefko, K

Results of Thyroid Function Assessment in Children and Adolescents with Hodgkin's Lymphoma Treated According to HD-97 Protocol

Assessment of Gonadal Function in Young Men Treated for Hodgkin's Lymphoma during Childhood and Adolescence

Taj, M

Challenges in Treating Hodgkin Lymphoma in a Developing Country: Children Hospital Lahore Experience

Tam, W

Beta-2 Microglobulin (B2 M) Genomic Alterations and Absent Protein Expression in Pediatric and Adolescent Classical Hodgkin Lymphoma

Tam, Y

Beta-2 Microglobulin (B2 M) Genomic Alterations and Absent Protein Expression in Pediatric and Adolescent Classical Hodgkin Lymphoma

Tayari, M

Long Non-Coding RNAs Are Commonly Deregulated in Hodgkin Lymphoma

Tchavdarova, L

Impact of Non-FDG-Avid Areas Inside a Tumour Mass in Paediatric Hodgkin Lymphoma (PHL) Patients

Tekkesin, F

Evaluation of FDG-PET/CT and Conventional Imaging Techniques in Pediatric Hodgkin Lymphoma Patients in a Single Center

Tekkeşin, F

Clinical Characteristics and Outcome of Pediatric Patients with Relapsed or Refractory Hodgkin Lymphoma: Gazi University Pediatric Oncology Experience

Terpstra, M

Long Non-Coding RNAs Are Commonly Deregulated in Hodgkin Lymphoma

Teruya-Feldstein, J

Beta-2 Microglobulin (B2 M) Genomic Alterations and Absent Protein Expression in Pediatric and Adolescent Classical Hodgkin Lymphoma

Thalheimer, FB

Re-fusion of Small Mononucleated Hodgkin Cells Leads to Multinucleated Reed-Sternberg Cells

Theodorou, I

Combined Linkage and Association Studies of Antibodies against EBV Antigens Confirm the Role of HLA Class II Variants in the Control of Anti-EBNA1 IgG Levels and in the Risk of Hodgkin's Lymphoma

Thompson, J

Outcomes and Patterns of Failure in Children/Adolescents with Low Risk Hodgkin Lymphoma (HL) who Are FDG-PET (PET3) Positive after AVPC Therapy

Thomson, J

Intensive Therapy Free Survival (ITFS) for Early-Stage Hodgkin Lymphoma (cHL) Including Chemotherapy and Radiation Therapy (IFRT) for Recurrence after Chemotherapy alone

Thum, P

Palliative Irradiation in a Primary Refractory Hodgkin Lymphoma Patient

Tilly, H

A Dedicated Program for Young Adults who Suffer from Cancer: Experience of the Centre Henri Becquerel, Rouen, France

Todesco, A

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Role of Interim FDG-PET for Mediastinal Response Assessment in Pediatric Hodgkin's Lymphoma (HL):Preliminary Results from the Italian AIEOP-LH2004 Protocol

Torres, MA

BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela

Tousseyn, T

Nodular Lymphocyte Predominant Hodgkin Lymphoma and T cell/Histiocyte Rich Large B Cell Lymphoma Endpoints of a Spectrum of one Disease?

Trovo', MG

Risk assessment of Solid Secondary Malignancies (SMN) in Childhood and Adolescent Hodgkin Lymphoma (HL) Treated with Radiotherapy (RT): Conventional RT vs. Helical Tomotherapy

Ueyama, J

Pediatric Hodgkin's Lymphoma in Japan

Urasinski, T

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Urdaneta de Ramos, B

BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela

van den Berg, A

HLA Associations in EBV Status Defined Subgroups of Classical Hodgkin Lymphoma

Long Non-Coding RNAs Are Commonly Deregulated in Hodgkin Lymphoma

Comparison of Serial Plasma Galectin-1, sCD163 and sCD30 with Plasma TARC Levels as Circulating Biomarkers for Response Evaluation in Classical Hodgkin Lymphoma

van Imhoff, G

HLA Associations in EBV Status Defined Subgroups of Classical Hodgkin Lymphoma

Comparison of Serial Plasma Galectin-1, sCD163 and sCD30 with Plasma TARC Levels as Circulating Biomarkers for Response Evaluation in Classical Hodgkin Lymphoma

Vankamamidi, VS

Hodgkin's Lymphoma-Eight Year Experience of a Tertiary Care Center in South India

Varan, A

Treatment Results of 102 Patients with Hodgkin Lymphoma under 5 Years of Age

Vaudre, G

Treatment of Children and Adolescents with Classical Hodgkin Lymphoma: Final Results of SFCE MDH03 Study

Vaughan, K

The Breast Screening after Radiotherapy Dataset (BARD): a National Initiative to Optimise Screening for Breast cancer in Female Hodgkin Lymphoma Survivors in England

Veenstra, R

HLA Associations in EBV Status Defined Subgroups of Classical Hodgkin Lymphoma

Velez-Bravo, V

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Vera-Lozada, G

M2 Macrophages but not M1 Macrophages Are Associated with Worst Outcome in Classical Hodgkin Lymphoma

Vera-Lozada, M

Genetic Variants of Interleukin 10 (IL10) are Associated with Clinical Outcome and Tumor Microenvironment Composition of Classical Hodgkin Lymphoma (cHL)

Veron, DA

Pediatric Hodgkin Lymphoma through Clinical Trials in Argentina in the Past 46 Years: The GATLA Experience

Visser, L

HLA Associations in EBV Status Defined Subgroups of Classical Hodgkin Lymphoma

Long Non-Coding RNAs Are Commonly Deregulated in Hodgkin Lymphoma

Comparison of Serial Plasma Galectin-1, sCD163 and sCD30 with Plasma TARC Levels as Circulating Biomarkers for Response Evaluation in Classical Hodgkin Lymphoma

Vivanco, J

Outcome of Spanish Patients outside Euronet-PHL-C1

Volkmer, I

Cancer/Testis Antigen 96 (Dual Specificity Protein Kinase TTK) is an Interesting Target for Hodgkin's Lymphoma

Identification of Endogenous Retrovirus Sequences that are Associated with Hodgkin's Lymphoma Specific Gene Expression

Hodgkin's Lymphoma Specific Transcripts and Minimal Residual Disease Detection

O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and resistance of Hodgkin's Lymphoma Cells against Dacarbazine

Vordermark, D

Impact of Non-FDG-Avid Areas Inside a Tumour Mass in Paediatric Hodgkin Lymphoma (PHL) Patients

Voss, S

Pleural Effusion in Intermediate Hodgkin Lymphoma COG Protocol AHOD0031-Evolution with Therapy and Association with Bulk Mediastinal Disease or Bone, Lung or Pleural Nodular Disease

Retrospective Review of Bone Changes in Hodgkin Lymphoma utilizing CT, 18F FDG-PET, 99mTc-MDPbone Scan and MRI from Children's Oncology Group Intermediate Stage Protocol AHOD0031

Outcomes and Patterns of Failure in Children/Adolescents with Low Risk Hodgkin Lymphoma (HL) who Are FDG-PET (PET3) Positive after AVPC Therapy

Intensive Therapy Free Survival (ITFS) for Early-Stage Hodgkin Lymphoma (cHL) Including Chemotherapy and Radiation Therapy (IFRT) for Recurrence after Chemotherapy alone

Wachowiak, J

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Wang, J

Phase 1/2 Study of Brentuximab Vedotin in Pediatric Pts with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 HL Data

Wappler, N

Identification of Endogenous Retrovirus Sequences that are Associated with Hodgkin's Lymphoma Specific Gene Expression

Warner, K

Re-fusion of Small Mononucleated Hodgkin Cells Leads to Multinucleated Reed-Sternberg Cells

Weathers, R

The Evolution of Pediatric Hodgkin Lymphoma Therapy: Contemporary Protocols Significantly Reduce Radiation Exposure of Normal Tissues

Weiser, C

Re-fusion of Small Mononucleated Hodgkin Cells Leads to Multinucleated Reed-Sternberg Cells

Westin, J

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Wheler, J

Significant Activity of the mTOR Inhibitor Sirolimus and HDAC Inhibitor Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma Patients

Whittemore, A

Longitudinal Evaluation of Health Status in Aging Pediatric Hodgkin Lymphoma Survivors: Report from the Childhood Cancer Survivor Study

Wieczorek, M

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Woessmann, W

Grey Zone Lymphoma in Children and Adolescents: Experience of Pediatric Hodgkin and Non-Hodgkin Study Groups

Wysocki, M

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Wziatek, A

Influence of Age on Treatment Results in Children and Adolescence with Hodgkin's Lymphoma Polish Experience

Xin, H

HLA Associations in EBV Status Defined Subgroups of Classical Hodgkin Lymphoma

Yalcin, B

Treatment Results of 102 Patients with Hodgkin Lymphoma under 5 Years of Age

Young, P

10 Year Experience of a National Breast Screening Programme Following Radiotherapy for Hodgkin Lymphoma in South East Wales

Yuen, H

Treatment Outcome of a Multi-Centre Clinical Study of Hodgkin Lymphoma: A Report by Hong Kong Paediatric Haematology and Oncology Study Group

Zanazzo, GA

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Zanella, G

Risk assessment of Solid Secondary Malignancies (SMN) in Childhood and Adolescent Hodgkin Lymphoma (HL) Treated with Radiotherapy (RT): Conventional RT vs. Helical Tomotherapy

Zecca, M

Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)

Zhao, S

Classical Hodgkin Lymphoma in Guatemalan Children of Age Less than Six Show High pPrevalence of EBV, HGAL and CD137: Prognostic and Therapeutic Implications

Zhou, R

The Evolution of Pediatric Hodgkin Lymphoma Therapy: Contemporary Protocols Significantly Reduce Radiation Exposure of Normal Tissues

Zucchetta, P

Role of Interim FDG-PET for Mediastinal Response Assessment in Pediatric Hodgkin's Lymphoma (HL):Preliminary Results from the Italian AIEOP-LH2004 Protocol